Minnesota HF 17: Generic or off-patent drugs; excessive price increases prohibited, attorney general authorized to take action against price increases, sale withdrawal prohibited, prescription drug affordability board and advisory council established, prescription drug cost reviews and remedies provided, and money appropriated.

Status: Committee report, to adopt as amended and re-refer to Health Finance and Policy (as of 2023-02-08)

State: Minnesota · Session: 2023-2024 · Bill: HF 17

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Stephenson, Bahner, Berg, Bierman, Cha, Curran, Elkins, Feist, Freiberg, Gomez, Greenman, Hanson, J., Hassan, Her, Hicks, Hollins, Hornstein, Hortman, Howard, Hussein, Jordan, Klevorn, Koegel, Kotyza-Witthuhn, Kozlowski

View Minnesota HF 17 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.